Outset Medical Q1 revenue down 6% to $27.9M; gross margin expands to 43.4%

Outset Medical, Inc.

2026-Q1 EPS reported -$1.03 revenue$27,863,000

Revenue $27.9M (-6% YoY); recurring revenue $22.5M roughly flat.
Gross margin 43.4% (up from 37.2% YoY); product gross margin record 52.4%, service margin record 25.5%.
Net loss narrowed to $19.0M from $25.8M; cash $161M at quarter end.
Reiterated FY 2026 revenue guidance $125-130M (5-9% growth) and non-GAAP gross margin low-to-mid 40%.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.